title: [Impact of a conjugated anti meningococcal A vaccine on notification of bacterial meningitis in West Burkina Faso (2009-2012)].
abstract: Burkina Faso is a sub-saharan African country completely included in the meningococcal meningitis belt. The western part of the country suffered from many meningococcal A epidemics, in spite of reactive collective campaigns with polysaccharide A vaccine. On 6th December 2010, Burkina Faso was the first African country to conduct a collective vaccination campaign of all the 1-29 years old population with a new conjugated meningococcal Avaccine (MenAfriVac™). Before this campaign, in Western Burkina (4,064,928 inhabitants, 27.5% of total population), a rehearsal of the staff of all peripheral medical laboratories has been conducted, with delivery of laboratory equipment, reactants, and possibility to transfer CSF specimens at the central level to confirm bacteriologic species in cause by latex, culture and PCR analysis. For this campaign, an administrative coverage of 100.3% was reached. A nearly complete disappearance of meningitis due to meningococcus A was recorded, but an increase of cases due to meningococcus X, W135. With the increase of quality of surveillance, and MenAfriVac™ vaccination showed its beneficial effect on meningococcus A meningitis. If we want however to impact on the number of recorded acute bacteriological meningitis, we will have to use multi-antigenic, if possible conjugated, meningococcal vaccines against locally circulating meningococcal species, the number of pneumococcal meningitis being contained by the recent inclusion in EPI of a 13-valent conjugated pneumococcal vaccine.
authors.affiliation: Centre Muraz, 01 BP 390, Bobo-Dioulasso, Burkina Faso.
authors.forename: S
authors.initials: S
authors.lastname: Ouangraoua
authors.forename: M
authors.initials: M
authors.lastname: Schlumberger
authors.forename: S
authors.initials: S
authors.lastname: Yaro
authors.forename: A S
authors.initials: AS
authors.lastname: Ouédraogo
authors.forename: S
authors.initials: S
authors.lastname: Sanou
authors.forename: A
authors.initials: A
authors.lastname: Drabo
authors.forename: T M
authors.initials: TM
authors.lastname: Yaméogo
authors.forename: R
authors.initials: R
authors.lastname: Ouedraogo
mesh_terms: D002050:Burkina Faso; D018563:Disease Notification / Q000706:statistics & numerical data*; D006801:Humans; D008585:Meningitis, Meningococcal / Q000517:prevention & control*; D022401:Meningococcal Vaccines; D012189:Retrospective Studies; D018074:Vaccines, Conjugate
chemical_list: C573970:MenAfriVac; D022401:Meningococcal Vaccines; D018074:Vaccines, Conjugate